All LY6K-specific CTL clones showed Ca2+ influx, IFN-γ production and cytotoxicity when co-cultured with LY6K-pulsed tumour cells, indicating that CTA peptide-based vaccination induces antigen-specific CTLs (99). The gene discussed is LY6K; the disease is neoplasm.